Nicotinic acid-induced insulin resistance is related to increased circulating fatty acids and fat oxidation but not muscle lipid content

Metabolism: Clinical and Experimental

Volumn 52, Issue 6, 2003, Pages 699-704

  Poynten, Ann M ^a,b   Gan, Seng Khee ^a,b   Kriketos, Adamandia D ^a,b   O'Sullivan, Anthony ^a,b   Kelly, John J ^a,b   Ellis, Bronwyn A ^a,b   Chisholm, Donald J ^a,b   Campbell, Lesley V ^a,b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LONG CHAIN FATTY ACID COENZYME A LIGASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; TRIACYLGLYCEROL; ANTILIPEMIC AGENT;

ADULT; ARTICLE; CALORIMETRY; CORRELATION ANALYSIS; DIET RESTRICTION; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFECT; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FLUSHING; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; GLUCOSE METABOLISM; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; METABOLIC PARAMETERS; MUSCLE CELL; MUSCLE LEVEL; MUSCLE MASS; NORMAL HUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUADRICEPS FEMORIS MUSCLE; QUANTITATIVE ANALYSIS; SIDE EFFECT; SKELETAL MUSCLE; SOLEUS MUSCLE; TIBIALIS ANTERIOR MUSCLE; BLOOD; CARBOHYDRATE DIET; FAT INTAKE; LIPID METABOLISM; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

ADULT; ANTILIPEMIC AGENTS; CALORIMETRY, INDIRECT; DIETARY CARBOHYDRATES; DIETARY FATS; FASTING; FATTY ACIDS; FATTY ACIDS, NONESTERIFIED; GLUCOSE; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MUSCLE, SKELETAL; NIACIN; OXIDATION-REDUCTION;

EID: 0041312408     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(03)00030-1     Document Type: Article

References (28)

1. Wang W, Basinger A, Neese RA, et al: Effects of nicotinic acid on fatty acid kinetics, fuel selection, and pathways of glucose production in women. Am J Physiol Endocrinol Metab 279:E50-59, 2000
2. Kahn SE, Beard JC, Schwartz MW, et al: Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes 38:562-568, 1989
3. Alvarsson M, Grill V: Impact of nicotinic acid treatment on insulin secretion and insulin sensitivity in low and high insulin responders. Scand J Clin Lab Invest 56:563-570, 1996
4. Kelly JJ, Lawson JA, Campbell LV, et al: Effects of nicotinic acid on insulin sensitivity and blood pressure in healthy subjects. J Hum Hypertens 14:567-572, 2000.
5. Boden G, Lebed B, Schatz M, et al: Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50:1612-1617, 2001
6. Kelley DE, Williams KV, Price JC, et al: Plasma fatty acids, adiposity, and variance of skeletal muscle insulin resistance in type 2 diabetes mellitus. J Clin Endocrinol Metab 86:5412-5419, 2001
7. Griffin ME, Marcucci MJ, Cline GW, et al: Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48:1270-1274, 1999
8. Roden M, Krssak M, Stingl H, et al: Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes 48:358-364, 1999
9. Kelley DE, Goodpaster BH: Skeletal muscle triglyceride: An aspect of regional adiposity and insulin resistance. Diabetes Care 24:933-941, 2001
10. Chalkley SM, Hettiarachchi M, Chisholm DJ, et al: Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat. Metabolism 47:1121-1126, 1998
11. Bachmann OP, Dahl DB, Brechtel K, et al: Effects of intravenous and dietary lipid challenge in intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 50:2579-2584, 2001
12. Lapsys NM, Kriketos AD, Lim-Fraser M, et al: Expression of genes involved in lipid metabolism correlate with perosixome proliferator-activated receptor gamma expression in human skeletal muscle. J Clin Endocrinol Metab 85:4293-4297, 2000
13. Ellis BA, Poynten A, Lowy AJ, et al: Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol Endocrinol Metab 279:E554-560, 2000
14. Boesch C, Slotboom J, Hoppeler H, et al: In vivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MR-spectroscopy. Magn Reson Med 37:484-493, 1997
15. Krssak M, Falk Petersen K, Dresner A, et al: Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: A 1H NMR spectroscopy study. Diabetologia 42:113-116, 1999
16. Rico-Sanz J, Hajnal JV, Thomas EL, et al: Intracellular and extracellular skeletal muscle triglyceride metabolism during alternating intensity exercise in humans. J Physiol (Lond) 510:615-622, 1998
17. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-223, 1979
18. O'Sullivan AJ, Kelly JJ, Hoffman DM, et al: Energy metabolism and substrate oxidation in acromegaly. J Clin Endocrinol Metab 80:486-491, 1995
19. Ferrannini E: The theoretical bases of indirect calorimetry: A review. Metabolism 37:287-301, 1988
20. Paradisi G, Smith L, Burtner C, et al: Dual energy x-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care 22:1310-1317, 1999
21. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10, 1997
22. Grundy SM, Vega GL, McGovern ME, et al: Efficacy, safety and tolerability of once-daily niacin for the treatment of dyslipidaemia associated with type 2 diabetes. Arch Intern Med 162:1568-1576, 2002
23. Randle PJ, Priestman DA, Mistry SC, et al: Glucose fatty acid interactions and the regulation of glucose disposal. J Cell Biochem 55:1-11, 1994
24. 12 skeletal muscle cells pretreated with palmitate. J Biol Chem 274:24202-24210, 1995
25. Krebs M, Krssak M, Nowotny P, et al: Free fatty acids inhibit the glucose stimulated increase of intramuscular glucose-6-phosphate concentration in humans. J Clin Endocrinol Metab 86:2153-2160, 2001
26. Hegarty BD, Cooney GJ, Kraegen EW, et al: Increased fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin resistant rats. Diabetes 51:1477-1484, 2002
27. Furler SM, Poynten AM, Kriketos AD, et al: Independent influences of central fat and skeletal muscle lipids on insulin sensitivity. Obes Res 9:535-543, 2001
28. Forouhi NG, Jenkinson G, Thomas EL, et al: Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men. Diabetologia 42:932-935, 1999